SC
MYOK

Samlyn Capital’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Samlyn Capital’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-256,096
Closed -$12M – 135
2020
Q1 		$12M Buy
256,096
+40,093
+19% +$2.57M 0.3% 65
2019
Q4 		$15.7M Sell
216,003
-119,418
-36% -$7.24M 0.33% 68
2019
Q3 		$17.5M Buy
335,421
+77,815
+30% +$4.14M 0.42% 64
2019
Q2 		$12.9M Buy
257,606
+37,000
+17% +$1.8M 0.27% 87
2019
Q1 		$11.5M Sell
220,606
-63,302
-22% -$2.92M 0.27% 76
2018
Q4 		$13.9M Buy
283,908
+182,681
+180% +$10.1M 0.33% 76
2018
Q3 		$6.6M Sell
101,227
-144,264
-59% -$8.48M 0.15% 106
2018
Q2 		$12.2M Buy
+245,491
New +$11.9M 0.29% 94

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return